# Sevoflurane-remifentanil EC50 (The 50% Effective Concentration) Values for LMA-Supreme Versus LMA ProSeal Insertion

> **NCT03003377** · PHASE4 · COMPLETED · sponsor: **Hospital General Universitario Gregorio Marañon** · enrollment: 45 (actual)

## Conditions studied

- Sevoflurane

## Interventions

- **DEVICE:** laryngeal mask supreme
- **DEVICE:** laryngeal mask proseal

## Key facts

- **NCT ID:** NCT03003377
- **Lead sponsor:** Hospital General Universitario Gregorio Marañon
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2016-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03003377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03003377, "Sevoflurane-remifentanil EC50 (The 50% Effective Concentration) Values for LMA-Supreme Versus LMA ProSeal Insertion". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03003377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*